NCT01530659View on ClinicalTrials.gov

Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Retinitis PigmentosaUsher Syndrome Type 2Usher Syndrome Type 3
Interventions
DRUG

NT-501

Study participants will undergo surgery to have an NT-501 Encapsulated Cell Therapy implant placed into the study eye.

PROCEDURE

Sham

Non-penetrating sham procedure to mimic implant procedure in the other eye.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

Sponsors
All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

Neurotech Pharmaceuticals

INDUSTRY

NCT01530659 - Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa | Biotech Hunter | Biotech Hunter